Tag Archives: NBRV

Top 5 Value Stocks To Invest In 2019

Crestwood Equity Partners (NYSE:CEQP) has been one of the best-performing MLPs of 2018. Overall, it has risen more than 45% through the end of August versus a sub-1% gain for the Alerian MLP ETF. Fueling Crestwood’s surge has been the notable turnaround in the company’s quarterly results, which have started rebounding after a challenging past few years.

Crestwood’s rally this year might have some investors wondering if it’s worth buying at today’s price. While it’s certainly not as cheap as it once was, the MLP still trades at a compelling valuation considering its growth prospects. Add that upside to its high-yielding distribution, and Crestwood looks like it could continue generating market-beating returns from here. 

Crestwood’s price might have increased, but it’s still a good value. Image source: Getty Images.

Top 5 Value Stocks To Invest In 2019: Kaman Corporation(KAMN)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Kaman (KAMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Kaman Aircraft (NYSE:KAMN) hit a new 52-week high and low on Wednesday . The stock traded as low as $67.95 and last traded at $68.00, with a volume of 2807 shares traded. The stock had previously closed at $67.07.

  • [By Joseph Griffin]

    Laurion Capital Management LP purchased a new position in shares of Kaman Co. (NYSE:KAMN) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 17,114 shares of the industrial products company’s stock, valued at approximately $1,192,000. Laurion Capital Management LP owned about 0.06% of Kaman as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Kaman (KAMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Value Stocks To Invest In 2019: Check Point Software Technologies Ltd.(CHKP)

Advisors’ Opinion:

  • [By ]

    Check Point Software Technologies (Nasdaq: CHKP) plummeted 6.4% when it only slightly beat Q1 expectations but guided lower for the year. Cybersecurity has gotten more competitive recently, and the company reported a 12% increase in marketing expenses through the first quarter. That spooked investors on the potential for slower sales growth and weaker profitability.

  • [By Max Byerly]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Check Point Software Technologies alerts:

    Managed Security Services Market Report 2018 – AT&T Inc., BT Group, Check Point Software Technologies Ltd., Cisco … (marketresearchnewswire.com) Are Institutions Shifting Their Positions in Check Point Software Technologies Ltd. (NASDAQ:CHKP)? (zeelandpress.com) DNC reports attempted cyber attack on voter database (seekingalpha.com) Why Is Check Point (CHKP) Down 1.1% Since Last Earnings Report? (finance.yahoo.com) Has Check Point Software Technologies Ltd’s (NASDAQ:CHKP) Earnings Momentum Changed Recently? (finance.yahoo.com)

    Several research firms have recently commented on CHKP. Stifel Nicolaus reaffirmed a “hold” rating and issued a $112.00 price objective (up from $95.00) on shares of Check Point Software Technologies in a report on Thursday, July 26th. Barclays reaffirmed a “hold” rating and issued a $120.00 price objective on shares of Check Point Software Technologies in a report on Thursday, July 26th. BMO Capital Markets upped their price objective on shares of Check Point Software Technologies from $108.00 to $130.00 and gave the company a “market perform” rating in a report on Thursday, July 26th. Morgan Stanley upped their price objective on shares of Check Point Software Technologies from $102.00 to $116.00 and gave the company an “equal weight” rating in a report on Thursday, July 26th. Finally, Piper Jaffray Companies reiterated a “hold” rating and issued a $110.00 target price on shares of Check Point Software Technologies in a research note on Thursday, July 26th. Twenty-one research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Check Point Software Technologies has a consensus rating of “Hold” and an average price target of $1

  • [By Chris Lange]

    Check Point Software Technologies Ltd.’s (NASDAQ: CHKP) short interest increased to 11.16 million shares from the previous 10.74 million. Shares were trading at $113.81, in a 52-week range of $93.76 to $119.20.

Top 5 Value Stocks To Invest In 2019: Nabriva Therapeutics AG(NBRV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Nabriva Therapeutics PLC – (NASDAQ:NBRV) shares saw strong trading volume on Monday . 908,177 shares traded hands during mid-day trading, an increase of 63% from the previous session’s volume of 558,242 shares.The stock last traded at $2.04 and had previously closed at $1.91.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Nabriva Therapeutics (NBRV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Nabriva Therapeutics PLC – (NASDAQ:NBRV) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 1,574,112 shares, a growth of 28.5% from the August 15th total of 1,224,631 shares. Currently, 3.4% of the company’s stock are short sold. Based on an average daily trading volume, of 315,802 shares, the short-interest ratio is currently 5.0 days.

  • [By Lisa Levin]

    Shares of Nabriva Therapeutics plc (NASDAQ: NBRV) were down 14 percent to $4.6666 despite positive topline results from Phase 3 Lefamulin trial.

    Carver Bancorp, Inc. (NASDAQ: CARV) was down, falling around 21 percent to $6.59 after surging 201.37 percent on Thursday.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Nabriva Therapeutics (NBRV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Nabriva Therapeutics PLC – (NASDAQ:NBRV) shares hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $4.20 and last traded at $4.39, with a volume of 8914 shares. The stock had previously closed at $4.29.

Top 5 Value Stocks To Invest In 2019: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Headlines about Intec Pharma (NASDAQ:NTEC) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intec Pharma earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 45.4513319646459 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    Media stories about Intec Pharma (NASDAQ:NTEC) have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intec Pharma earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.6707447165993 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Joseph Griffin]

    Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.

Top 5 Value Stocks To Invest In 2019: Tanger Factory Outlet Centers Inc.(SKT)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Finding cheap dividend stocks often means delving into companies that are working through some sort of problem. The hard part is figuring out if the problems are surmountable or, potentially, terminal. Investors have left Tanger Factory Outlet Centers (NYSE:SKT) and VEREIT (NYSE:VER) in the bargain bin. But you could find good reasons to think these cheap dividend stocks are worth buying when you dig into the details just a little.

  • [By Ethan Ryder]

    Shares of Tanger Factory Outlet Centers Inc. (NYSE:SKT) saw an uptick in trading volume on Friday . 9,958,404 shares changed hands during mid-day trading, an increase of 507% from the previous session’s volume of 1,640,557 shares.The stock last traded at $23.92 and had previously closed at $23.26.

  • [By Steve Symington, Leo Sun, and Reuben Gregg Brewer]

    To that end, we asked three Motley Fool contributors to each identify a top dividend stock that yields at least 4%. Read on to learn why they like Tanger Factory Outlet Centers (NYSE:SKT), W.P. Carey (NYSE:WPC), and Las Vegas Sands (NYSE:LVS).

  • [By Reuben Gregg Brewer]

    Today, ExxonMobil Corporation (NYSE:XOM), Tanger Factory Outlet Centers, Inc. (NYSE:SKT), and AT&T, Inc. (NYSE:T) are all offering big yields for investors willing to think long term.

  • [By Brian Feroldi, Leo Sun, and Demitrios Kalogeropoulos]

    Want proof? We asked these Motley Fool investors to highlight a dividend stock that pays a higher yield than Verizon. Here’s why they picked Tanger Factory Outlets (NYSE:SKT), Cedar Fair (NYSE:FUN), and STORE Capital (NYSE:STOR). 

  • [By Reuben Gregg Brewer]

    Wall Street is an interesting beast, acting as a weighing machine over the long term but subject to emotional gyrations over shorter periods. It can be hard to fight the mood of the market, but if you can think long term while others are focused on the short term, you can find some solid investments. Three that are worth a very close look today are high-yielding ExxonMobil (NYSE:XOM), Tanger Factory Outlet Centers (NYSE:SKT), and General Mills (NYSE:GIS). Here’s a quick rundown of why you might want to buy these stocks right now.

Hot Low Price Stocks To Invest In 2019

What happened

Shares of Rogers Corp. (NYSE:ROG) gained 19.9% in April 2017, according to data from S&P Global Market Intelligence.

So what

The company reported first-quarter results on April 26, sending share prices nearly 12% higher the next day. Rogers saw 27% year-over-year sales growth and 79% higher earnings, leaving analyst estimates far behind in both cases.

A Rogers engineer, hard at work on next-generation battery materials. Image source: Rogers.

Now what

Rogers shares have now gained 72% over the last 52 weeks, trading steadily near all-time highs. The maker of specialized materials used in battery systems and wireless antennas has consistently delivered solid earnings surprises over the last three years, often coupled with equally strong revenue wins.

This company is poised to continue making a killing in several emerging markets, including the Internet of Things and automotive computing. Best of all, Rogers is winning competitive contracts without resorting to pricing discounts. Trailing operating margins have increased from 12.4% to 14.2% over the last four quarters. In other words, clients are choosing Rogers over rival materials providers for other reasons than low prices, such as product quality and dependable ordering and delivery processes.

Hot Low Price Stocks To Invest In 2019: Starwood Hotels & Resorts Worldwide, Inc.(HOT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Hydro Protocol (CURRENCY:HOT) traded up 15.6% against the US dollar during the 24-hour period ending at 19:00 PM ET on May 5th. During the last week, Hydro Protocol has traded up 93.2% against the US dollar. One Hydro Protocol token can currently be purchased for approximately $0.10 or 0.00001044 BTC on major exchanges including BigONE, DDEX and OKEx. Hydro Protocol has a total market cap of $72.13 million and approximately $1.91 million worth of Hydro Protocol was traded on exchanges in the last day.

  • [By Ethan Ryder]

    Independent Research set a €156.00 ($185.71) price objective on Hochtief (FRA:HOT) in a research note issued to investors on Friday morning. The brokerage currently has a neutral rating on the stock.

  • [By Ethan Ryder]

    Holo (CURRENCY:HOT) traded down 9.1% against the US dollar during the 24 hour period ending at 8:00 AM Eastern on June 11th. Holo has a total market cap of $109.14 million and $2.40 million worth of Holo was traded on exchanges in the last day. One Holo token can now be purchased for about $0.0008 or 0.00000012 BTC on popular cryptocurrency exchanges including IDEX, Radar Relay, Hotbit and Fatbtc. During the last seven days, Holo has traded down 17.3% against the US dollar.

Hot Low Price Stocks To Invest In 2019: SEACOR Holdings, Inc.(CKH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    State of Tennessee Treasury Department reduced its stake in shares of Seacor Holdings, Inc. (NYSE:CKH) by 9.5% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 11,943 shares of the oil and gas company’s stock after selling 1,254 shares during the period. State of Tennessee Treasury Department owned approximately 0.07% of Seacor worth $610,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Headlines about Seacor (NYSE:CKH) have been trending somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Seacor earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned media headlines about the oil and gas company an impact score of 45.3315874804175 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Hot Low Price Stocks To Invest In 2019: Full House Resorts, Inc.(FLL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Huazhu Group (NASDAQ: HTHT) and Full House Resorts (NASDAQ:FLL) are both consumer discretionary companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership.

Hot Low Price Stocks To Invest In 2019: Nabriva Therapeutics AG(NBRV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Nabriva Therapeutics PLC – (NASDAQ:NBRV) shares hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $4.20 and last traded at $4.39, with a volume of 8914 shares. The stock had previously closed at $4.29.

  • [By Lisa Levin]

    Shares of Nabriva Therapeutics plc (NASDAQ: NBRV) were down 14 percent to $4.6666 despite positive topline results from Phase 3 Lefamulin trial.

    Carver Bancorp, Inc. (NASDAQ: CARV) was down, falling around 21 percent to $6.59 after surging 201.37 percent on Thursday.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Nabriva Therapeutics (NBRV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Ethan Ryder]

    Nabriva Therapeutics (NASDAQ:NBRV) last issued its earnings results on Tuesday, May 8th. The biotechnology company reported ($0.36) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.59) by $0.23. Nabriva Therapeutics had a negative return on equity of 79.30% and a negative net margin of 600.34%. The firm had revenue of $7.55 million for the quarter, compared to analyst estimates of $1.27 million. equities analysts anticipate that Nabriva Therapeutics will post -1.9 EPS for the current fiscal year.

Hot Low Price Stocks To Invest In 2019: Schwab US Large-Cap ETF (SCHX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Milestone Group Inc. decreased its stake in Schwab US Large-Cap ETF (NYSEARCA:SCHX) by 4.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 63,425 shares of the company’s stock after selling 2,710 shares during the period. Schwab US Large-Cap ETF makes up 0.7% of Milestone Group Inc.’s investment portfolio, making the stock its 19th largest holding. Milestone Group Inc.’s holdings in Schwab US Large-Cap ETF were worth $4,001,000 as of its most recent filing with the Securities & Exchange Commission.

Hot Value Stocks For 2018

Hit games are a weird thing. They can sometimes come out of nowhere, and sometimes can be considered an inevitability. Many thought games such as Grand Theft Auto V by Take-Two Interactive (NASDAQ:TTWO) or any version of Call of Duty by Activision (NASDAQ:ATVI) would undoubtedly do very well and would likely be hits. Others took the market by surprise, Pok茅mon Go by Niantic/Nintendo (OTCPK:NTDOY) and Kim Kardashian Hollywood by Glu Mobile (NASDAQ:GLUU) come to mind. In general, it seems, mobile games have a greater propensity to come from the flank, becoming hit games to the surprise of even the most learned gaming experts. Maybe it has something to do with the mobile form factor, or maybe it’s the sheer amount of capital thrown at hit console games nearly guaranteeing they will be successful.

The mobile battlefield is full of games that came out of nowhere, Candy Crush, Clash of Clans, Summoners War, Episode – Choose Your Story and more recently, Archery King. The hits of tomorrow on this field are potentially not even out yet, at the very least, not a “hit” game yet. Mobile gaming executives have tried their hardest; they don’t want their industry to be viewed as hit-driven. No, they try to sell the portfolio of games narrative as much as investors have the patience to hear about it. Investors don’t seem to care. A nice solid portfolio is great but when the portfolio often produces ever-diminishing revenue quarter after quarter investors become tired of hearing how great a company’s “portfolio” might be. What we have seen in the industry are names that investors have become tired with, picked off by larger, more established gaming companies that see the value.

Hot Value Stocks For 2018: Nabriva Therapeutics AG(NBRV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

Hot Value Stocks For 2018: S&W Seed Company(SANW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    S&w Seed (NASDAQ:SANW) – Equities researchers at B. Riley decreased their Q3 2019 earnings per share (EPS) estimates for S&w Seed in a research note issued to investors on Thursday, May 10th. B. Riley analyst S. Sherbetchyan now anticipates that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.01. B. Riley has a “Buy” rating and a $5.50 price objective on the stock.

Hot Value Stocks For 2018: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Genomic Health (NASDAQ:GHDX) – Equities researchers at Piper Jaffray issued their Q2 2018 earnings per share (EPS) estimates for shares of Genomic Health in a research report issued on Wednesday, May 2nd. Piper Jaffray analyst W. Quirk expects that the medical research company will post earnings of $0.06 per share for the quarter. Piper Jaffray has a “Hold” rating and a $33.00 price target on the stock. Piper Jaffray also issued estimates for Genomic Health’s Q3 2018 earnings at $0.11 EPS, Q4 2018 earnings at $0.14 EPS, FY2018 earnings at $0.44 EPS, Q1 2019 earnings at $0.16 EPS, Q2 2019 earnings at $0.18 EPS, Q3 2019 earnings at $0.12 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.62 EPS.

  • [By Brian Orelli]

    Cancer-test maker Genomic Health (NASDAQ:GHDX) started the year on a high note, posting double-digit revenue growth, and would have turned a profit if not for an $8.5 millionone-time charge for stopping development of the Oncotype SEQ Liquid Select test, which was announced on the last quarterly call.

Hot Energy Stocks To Invest In Right Now

For the past few years, it has been slim pickings for dividend investors. High yields have been hard to find, and what opportunities did appear to exist, such as in the energy sector, often led to sizable losses that more than erased the seemingly attractive dividend yields.

However, the main problem for yield investors — low interest rates — is starting to resolve itself. The 10-year treasury yield has now doubled since its low. The Donald Trump presidency is bringing hopes of faster economic growth and higher inflation, thus powering up interest rates. New Federal Reserve chief Jerome Powell seems committed to a gradual but firm path toward higher rates going forward.

This has caused big declines for REITs (real estate investment trusts) and defensive stocks that yield-focused investors tend to gravitate toward. This dynamic has set up some outstanding bargains for dividend investors in May. The market rarely stops at fair value during a correction, some of these 10 stocks are tipping well into deep value territory. Let’s get started.

Hot Energy Stocks To Invest In Right Now: Nabriva Therapeutics AG(NBRV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Nabriva Therapeutics plc (NASDAQ: NBRV) shares shot up 37 percent to $9.38 after the company disclosed that its Phase 3 trial evaluating IV and oral lefamulin met all primary FDA and EMA endpoints.

  • [By Lisa Levin]

    Shares of Nabriva Therapeutics plc (NASDAQ: NBRV) got a boost, shooting up 10 percent to $9.71. Nabriva Therapeutics announced a $80 million common stock offering.

Hot Energy Stocks To Invest In Right Now: Navios Maritime Partners LP(NMM)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Meanwhile, Safe Bulkers, Inc. (NYSE: SB) rose $0.73 throughout the 2016, Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) fell $1.69 and Navios Maritime Partners L.P. (NYSE: NMM) dropped $0.93.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Navios Maritime Partners (NMM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

Hot Energy Stocks To Invest In Right Now: Matador Resources Company(MTDR)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Our peer group is up an average of 46% over the past 4 weeks in response to a 30% rebound in the 12-month strip NYMEX oil price. Some of the largest gainers include Hold and Sell rated stocks that we would not chase such asDenbury Resources (Sell, +138%), Halcon Resources (HK) (Sell, +147%), Jones Energy (JONE) (Hold, +166%), Rex Energy (REXX) (Sell, +60%), Sanchez Energy (SN) (Hold, +93%), Ultra Petroleum (UPL) (Sell, +61%), andWhiting Petroleum (Hold, +103%), which have outperformed the E&P Index (+32%) over the same time period. Balance sheets and/or well level returns remain challenged for these companies despite improved oil prices. While we believe oil markets should re-balance over the next 12 to 15 months, the recent recovery to $40 could reverse during 2Q16 as bloated inventories continue to rise, new volumes from Iran pressure an oversupplied market, and a highly anticipated decline in non-OPEC supply (especially in the U.S.), is not as steep as expected. The risk of an oil price retracement, which would significantly pressure the recent out-performers, outweighs the upside in these stocks, in our view. However, we are raising our target prices on Buy ratedAnadarko Petroleum ($54 from $48), Concho Resources (CXO) ($120 from $109), Matador Resources (MTDR) ($22 from $21),Noble Energy (NBL) ($40 from $34), SM Energy (SM) ($22 from $15), Rice Energy ($14 from $12), Pioneer Natural Resources (PXD) ($155 from $135),Continental Resources ($32 from $28), and Parsley Energy (PE) ($24 from $23). We believe our Buy-rated stocks are better positioned to weather challenging oil markets.

  • [By Ezra Schwarzbaum]

    But despite positioning that would thrash other similar companies, Resolute fought through thanks to significant and efficient productivity in its Delaware Basin assets. Wangler believes the strengthening of previous concern areas will make the company a solid investment.

    Matador Resources Co (NYSE: MTDR), $32 Price Target

    Matador has grown its reserves throughout the commodity cycle, as well as its production and cash flow. Haas also likes the company’s history of identifying and acquiring acreage early and cheaply. Much of the analyst’s positive outlook is derived from Matador’s successful monetization of midstream assets and pattern of reinvestment.